Evolus (EOLS) Restructuring Costs (2020 - 2025)
Evolus (EOLS) posted Restructuring Costs of $1.4 million for Q3 2025, down 51.18% on a QoQ basis from $3.0 million in Q2 2020.
Evolus (EOLS) Restructuring Costs (2020 - 2025) Analysis & Trends
Evolus' Restructuring Costs history runs 2 years deep, the most recent figure standing at $1.4 million for Q3 2025.
- Quarterly Restructuring Costs changed N/A year-over-year to $1.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (changed N/A YoY) and the FY2025 annual result came in at $1.4 million, changed N/A from the prior year.
- Restructuring Costs was $1.4 million for Q3 2025 at Evolus, down from $3.0 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $1.4 million in Q3 2025 and bottomed at $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2020 | 2.96 Mn |